For the second time in the past few months, a Democratic lawmaker is after Pfizer (PFE) to explain its pricing decisions, especially now that the drug maker is lifting a brief, self-imposed ban on price hikes with plans to boost the cost of more than 40 medicines next month.

In a letter to Pfizer chief executive Ian Read, Sen. Tammy Baldwin (D-Wis.) chastised him for “playing political games” by proceeding with the price hikes and for failing to answers questions that she posed last July, when Read tried to appease President Trump by rolling back a slew of increases.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy